Telomerase activity in gastrointestinal stromal tumors

Cancer

Volumn 83, Issue 10, 1998, Pages 2060-2066

  Sakurai, Shinji ^a   Fukayama, Masashi ^a   Kaizaki, Yasuharu ^a   Saito, Ken ^a   Kanazawa, Kyotaro ^a   Kitamura, Masatsugu ^b   Iwasaki, Yoshiaki ^b   Hishima, Tsunekazu ^b   Hayashi, Yukiko ^b   Koike, Morio ^b  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

Gastrointestinal stromal tumor (GIST); Ki 67; P53; Telomerase; Telomere

Indexed keywords

ALPHA ACTIN; CD34 ANTIGEN; ENZYME INHIBITOR; KI 67 ANTIGEN; PROTEIN P53; PROTEIN S 100; TELOMERASE; VIMENTIN;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GASTROINTESTINAL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 15144348712     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19981115)83:10<2060::aid-cncr3>3.0.co;2-%23     Document Type: Article

References (36)

1. Ueyama T, Guo KJ, Hashimoto H, Daimaru Y, Enjoji M. A clinicopathologic and immunohistochemical study of gastrointestinal stromal tumors. Cancer 1992;69:947-55.
2. Franquemont DW, Frierson HF Jr. Muscle differentiation and clinicopathological features of gastrointestinal stromal tumors. Am J Surg Pathol 1992;16:947-54.
3. Ma CK, Amin MB, Kintanar E, Linden MD, Zarbo RJ. Immunohistologic characterization of gastrointestinal stromal tumors: a study of 82 cases compared with 11 cases of leiomyomas. Mod Pathol 1993;6:139-44.
4. Lauwers GY, Erlandson RA, Casper ES, Brennan MF, Woodruff JM. Gastrointestinal autonomic nerve tumors. Am J Surg Pathol 1993;17:887-97.
5. Vrettou E, Karkavelas G, Christoforidou B, Meditskou S, Papadimitriou CS. Immunohistochemical phenotyping and PCNA detection in gastrointestinal stromal tumors. Anticancer Res 1995;15:943-50.
6. Rosai J. Pathology. In: Rosai J, editor. Ackermans surgical pathology. 8th edition. St. Louis: Mosby-Year Book, Inc., 1996:646.
7. Amin MB, Ma CK, Linden MD, Kubus JJ, Zarbo RJ. Prognostic value of proliferating cell nuclear antigen index in gastric stromal tumors. Correlation with mitotic count and clinical outcome. Am J Clin Pathol 1993;100:428-32.
8. Franquemont DW. Differential and risk assessment of gastrointestinal stromal tumors. Am J Clin Pathol 1995;103:41-7.
9. Ranchod M, Kempson RL. Smooth muscle tumors of the gastrointestinal tract and retroperitoneum. A pathologic analysis of 100 cases. Cancer 1977;39:255-62.
10. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989;59:521-9.
11. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-5.
12. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992;11:1921-9.
13. Morrison SJ, Prowse KR, Ho P, Weissman IL. Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity 1996;5:207-16.
14. Morrison SJ, Prowse KR, Ho P, Weissman IL. Telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells (Dayt) 1996;14:239-48.
15. Bachor CH, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 1996;93:6476-81.
16. Yasumoto S, Kunimura C, Kikuchi K, Tahara H, Ohji H, Yamamoto H. Telomerase activity in normal human epithelial cells. Oncogene 1996;18:433-9.
17. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995;155:3711-5.
18. Harley CB, Futcher AB, Greider CW. Telomeres shorten during aging of human fibroblasts. Nature 1990;345:458-60.
19. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF. Telomerase activity in small-cell and non-small-cell lung cancer. J Natl Cancer Inst 1995;87:895-902.
20. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y. Telomerase activity in gastric cancer. Cancer Res 1995;55:3258-62.
21. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1995;1:249-55.
22. Nouso K, Urabe Y, Higashi T, Nakatsukasa H, Hino N, Ashida K. Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma. Cancer 1996;78:232-6.
23. Hiyama E, Gollahon L, Kataoka T, Kuroi K, Yokoyama T, Gazdar AF. Telomerase activity in human breast tumors. J Natl Cancer Inst 1996;88:116-22.
24. Sommerfeld HJ, Meeker AK, Piatyszek MA, Bova GS, Shay JW, Coffey DS. Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res 1996;56:218-22.
25. Kordek R, Biernat W, Alwasiak J, Liberski PP. Proliferating cell nuclear antigen (PCNA) and Ki-67 immunopositivity in human astrocytic tumours. Acta Neurochir (Wien) 1996;138:509-12.
26. Hepburn PJ, Glynne-Jones E, Goddard L, Gee M, Harper ME. Cell proliferation in prostatic carcinoma: comparative analysis of Ki-67, MIB-1 and PCNA. Histochem J 1995;27:196-203.
27. Hayashi Y, Fukayama M, Koike M, Kaseda S, Ikeda T, Yokoyama T. Cell-cycle analysis detecting endogenous nuclear antigen: comparison with BrdU-in vivo labelling and an application to lung tumors. Acta Pathol Jpn 1993;43:313-9.
28. Miettinen M, Viroolainen M, Rikala MS. Gastrointestinal stromal tumors: value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. Am J Surg Pathol 1995;19:207-16.
29. Shay JW. Telomerase in human development and cancer. J Cell Physiol 1997;173:266-70.
30. Sakurai S, Sano T, Nakajima T. Clinicopathological and molecular biological studies of gastric adenomas with special reference to p53 abnormality. Pathol Int 1995;45:51-7.
31. Sakurai S, Sano T, Maeshima A, Kashiwabara K, Oyama T, Fukuda T. Gastric adenoma-carcinoma sequence with special reference to p53 and Ki-ras gene alterations. Virchows Arch 1995;427:119-24.
32. Hirota S, Isozaki K, Yasuhiro M, Hashimoto K, Nishida T, Ishiguro S, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998;279:577-80.
33. Huminiecki L. Telomerase as a therapeutic target. Acta Biochim Pol 1996;43:531-8.
34. Kanazawa Y, Ohkawa K, Ueda K, Mita E, Takehara T, Sasaki Y. Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells. Biochem Biophys Res Commun 1996;225:570-6.
35. Fletcher TM, Salazar M, Chen SF. Human telomerase inhibition by 7-deaza-2'-deoxypurine nucleoside triphosphates. Biochemistry 1996;35:15611-7.
36. Raymond E, Sun D, Chen SF, Windle B, Von-Hoff DD. Agents that target telomerase and telomeres. Curr Opin Biotechnol 1996;7:583-91.